Prosensa Holding N.V. Press Releases

Get RNA Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading RNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Prosensa Announces Intent to Voluntarily Delist From NASDAQ
1/30/2015 8:30:00 AM - GlobeNewswire

BioMarin Announces Final Results of Tender Offer for Prosensa's Shares and Completion of Subsequent Offering Period
1/30/2015 8:00:00 AM - GlobeNewswire

BioMarin Announces Completion of Tender Offer for Prosensa''s Shares and Commences Subsequent Offering Period
1/15/2015 8:00:00 AM - GlobeNewswire

Prosensa Announces Shareholder Approval of Certain Matters Relating to the BioMarin Tender Offer
1/13/2015 8:41:00 AM - GlobeNewswire

BioMarin and Prosensa Announce Expiration of the Hart-Scott-Rodino Waiting Period for BioMarin''s Proposed Acquisition of Prosensa
12/24/2014 1:15:00 PM - GlobeNewswire

PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/12/2014 12:40:00 PM - PR Newswire

Prosensa Wins Scrip ''Biotech Company of the Year'' 2014 Award
12/8/2014 8:00:00 AM - GlobeNewswire

Prosensa Holding N.V. Acquisition By BioMarin Pharmaceutical Inc. May Not Be In The Best Interests of RNA Shareholders
12/3/2014 4:11:00 PM - PR Newswire
▼-1.16 % Price Change since this news event. The Volume Ratio is 1.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day

INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Prosensa Holding N.V. (RNA) Over the Proposed Sale of the Company to BioMarin Pharmaceutical Inc.
11/25/2014 7:00:00 PM - Business Wire

PROSENSA SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by BioMarin May be Unfair to Shareholders
11/24/2014 11:33:00 AM - Business Wire

BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio
11/24/2014 6:00:00 AM - GlobeNewswire

Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments
11/17/2014 7:00:00 AM - GlobeNewswire

Cure Duchenne and Prosensa to Present Collaboration at Partnering for Cures Conference
11/12/2014 3:02:00 PM - Business Wire
▲61.00 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day

Prosensa Holding N.V. to Webcast Conference Call Discussing 3rd Quarter 2014 Financial Results and Corporate Update on November 17, 2014
11/10/2014 8:00:00 AM - GlobeNewswire

Prosensa to Present at Upcoming Investor Conferences
11/7/2014 10:56:00 AM - GlobeNewswire